Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IRINOTECAN vs MITOXANTRONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IRINOTECAN vs MITOXANTRONE: Safety Overview

Metric IRINOTECAN MITOXANTRONE
Total FAERS Reports 27,965 4,166
Deaths Reported 4,530 995
Death Rate 16.2% 23.9%
Hospitalizations 10,384 1,556
Average Patient Age 58.7 yrs 37.0 yrs
% Female Patients 41.4% 48.0%
FDA Approval Date Apr 11, 2022 Apr 11, 2006
Manufacturer Armas Pharmaceuticals Inc. Meitheal Pharmaceuticals Inc.
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription Discontinued